Harnessing red grape pomace extract for sustainable broad-spectrum photoprotection in a reconstructed human epidermis model
Red grape pomace, a major by-product of the winemaking industry, represents a sustainable source of bioactive polyphenols with high nutraceutical and cosmetic potential. In this study, a standardized grape pomace extract (GPE) was developed from quality-controlled dried pomace, compliant with European Pharmacopoeia requirements for heavy metals, microbiological purity, and residual moisture. Phytochemical profiling by LC-DAD-ESI-MS/MS revealed a complex composition dominated by anthocyanins-primarily malvidin-3-<i>O</i>-glucoside-alongside lignans, stilbenes, and flavonols. The extract showed a high total phenolic content (2.64 g GAE/100 g) and exhibited strong, concentration-dependent antioxidant activity, with the highest efficacy in FRAP and ORAC assays, and significant anti-inflammatory effects in protein denaturation and protease inhibition tests. GPE demonstrated excellent photochemical stability and was incorporated into a lipid-based cosmetic formulation (SS + GPE) to assess its safety and photoprotective efficacy in a reconstructed human epidermis (RHE) model exposed to UVA (26 J/cm<sup>2</sup>) and UVB (1.5 J/cm<sup>2</sup>) radiation. Both GPE and SS + GPE treatments markedly reduced ROS, NO, and IL-1α production (up to 60%-65% reduction vs. irradiated control) while maintaining cell viability above 90%. Histological analysis further confirmed the structural protection of the epidermis, showing fewer dyskeratotic cells, restored intercellular cohesion, and normalization of keratinization. Overall, these results demonstrate that GPE is a safe, photostable, and multifunctional bioactive extract capable of counteracting UV-induced oxidative and inflammatory damage. This study provides a comprehensive and sustainable strategy for the upcycling of red grape pomace into high value dermocosmetic formulations with proven broad-spectrum photoprotective efficacy.
Authors
- Domenico Trombetta (ORCID: https://orcid.org/0000-0003-4358-5224)
- Mariarosaria Ingegneri
- Francesco Merlino (ORCID: https://orcid.org/0000-0002-9607-229X)
- Antonella Smeriglio (ORCID: https://orcid.org/0000-0002-9756-304X)
- Giancarlo Tonon
- Annarita La Neve
- Luca Mastracci
- Diego Bosco
- Chiara Brenna
- Marta Mangano
Institutions
- University of Messina (IT)
- Synlab Czech (Czechia) (CZ)
- Accenture (Italy) (IT)
- Ospedale Policlinico San Martino (IT)
- University of Genoa (IT)
- Evotec (United States) (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fphar.2025.1744377
- Primary Topic
- Skin Protection and Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00